Bayesian Capital Management’s Hologic HOLX Stock Holding History

Bayesian Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,889	Closed	-$643K	–	816
2024 Q3	$643K	Sell	7,889 -15,145	-66%	-$1.21M	0.08%	325
2024 Q2	$1.71M	Buy	+23,034	New	+$1.73M	0.2%	140
2024 Q1	–	Sell	-67,034	Closed	-$4.79M	–	917
2023 Q4	$4.79M	Buy	+67,034	New	+$4.67M	0.51%	36
2023 Q1	–	Sell	-15,500	Closed	-$1.16M	–	925
2022 Q4	$1.16M	Buy	+15,500	New	+$1.1M	0.17%	153
2021 Q4	–	Sell	-5,300	Closed	-$391K	–	439
2021 Q3	$391K	Buy	+5,300	New	+$397K	0.11%	220
2021 Q2	–	Sell	-13,513	Closed	-$1M	–	508
2021 Q1	$1M	Sell	13,513 -17,200	-56%	-$1.31M	0.23%	122
2020 Q4	$2.24M	Buy	+30,713	New	+$2.17M	0.58%	32
2020 Q1	–	Sell	-4,200	Closed	-$219K	–	851
2019 Q4	$219K	Buy	+4,200	New	+$209K	0.04%	509
2019 Q1	–	Sell	-10,600	Closed	-$436K	–	644
2018 Q4	$436K	Buy	+10,600	New	+$435K	0.09%	316
2017 Q1	–	Sell	-36,170	Closed	-$1.45M	–	528
2016 Q4	$1.45M	Buy	+36,170	New	+$1.4M	0.36%	65

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bayesian Capital Management's HOLX Position: Q4 2024 in Review

Bayesian Capital Management sold out of Hologic (HOLX) in Q4 2024, closing a stake of 7,889 shares — an estimated $643K sold.

Bayesian Capital Management first reported a position in HOLX in Q4 2016 and held it in 10 quarters. The position peaked at $4.79M in Q4 2023. 718 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

Bayesian Capital Management reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
Bayesian Capital Management sold 7,889 Hologic shares in Q4 2024, an estimated $643K.
Bayesian Capital Management first reported a position in Hologic in Q4 2016 and held it in 10 quarters.
Bayesian Capital Management's Hologic position peaked at $4.79M in Q4 2023.
718 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.